A. Zarghami, S. A. Mirmalek. Differentiating Primary and Recurrent Lesions in Patients with a History of Breast Cancer: A Comprehensive Review: Differentiating Primary and Recurrent Lesions in Patients with BC. Galen Med J 2024; 13: e3340.

R. J. O. Dowling, K. Kalinsky, D. F. Hayes. Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations. JNCI Cancer Spectr 2019; 3(4): pkz050.

J. Morales-Valencia, G. David. The origins of cancer cell dormancy. Curr Opin Genet Dev 2022; 74: 101914.

J. A. Aguirre-Ghiso. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007; 7(11): 834-846.

I. Heidrich, B. Deitert, S. Werner, K. Pantel. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors. Cancer Metastasis Rev 2023; 42(1): 161-182.

J. Agudo, J. A. Aguirre-Ghiso, M. Bhatia, L. A. Chodosh, A. L. Correia, C. A. Klein. Targeting cancer cell dormancy. Nat Rev Cancer 2024; 24(2): 97-104.

S. Malladi, D. G. Macalinao, X. Jin. Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell 2016; 165(1): 45-60.

X lei Gao, M. Zheng, H fan Wang. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway. BMC Cancer 2019; 19(1): 743.

J. A. A. Ghiso, K. Kovalski, L. Ossowski. Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling. J Cell Biol 1999; 147(1): 89-104.

S. B. Chia, B. J. Johnson, J. Hu. Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature 2025; 645(8080): 496-506.

M. O. Laguillaumie, S. Titah, A. Guillemette. Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia. Biol Res 2024; 57(1): 59.

B. Li, L. Zheng, J. Yang, L. Qu. Targeting oncogene-induced cellular plasticity for tumor therapy. Adv Biotechnol 2024; 2(3): 24.

F. Zhao, T. Zhang, J. Wei. Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression. eBioMedicine 2024; 109: 105398.

A. Moorman, E. K. Benitez, F. Cambulli. Progressive plasticity during colorectal cancer metastasis. Nature 2025; 637(8047): 947-954.

X. Yang, X. Liang, M. Zheng, Y. Tang. Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis. Front Oncol 2018; 8: 505.

C. D’Antonio, G. L. Liguori. Dormancy and awakening of cancer cells: the extracellular vesicle-mediated cross-talk between Dr. Jekill and Mr. Hyde. Front Immunol 2024; 15: 1441914.

H. Y. Min, H. Y. Lee. Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies. Cancer Res Treat 2023; 55(3): 720-736.

H. Endo, M. Inoue. Dormancy in cancer. Cancer Sci 2019; 110(2): 474-480.

K. Truskowski, S. R. Amend, K. J. Pienta. Dormant cancer cells: programmed quiescence, senescence, or both?. Cancer Metastasis Rev 2023; 42(1): 37-47.

C. M. Neophytou, T. C. Kyriakou, P. Papageorgis. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy. Int J Mol Sci 2019; 20(24): 6158.

A. C. Yeh, S. Ramaswamy. Mechanisms of Cancer Cell Dormancy—Another Hallmark of Cancer?. Cancer Res 2015; 75(23): 5014-5022.

S. Bakhshandeh, C. Werner, P. Fratzl, A. Cipitria. Microenvironment-mediated cancer dormancy: Insights from metastability theory. Proc Natl Acad Sci 2022; 119(1): e2111046118.

F. Francescangeli, M. L. De Angelis, R. Rossi. Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution. Cancer Metastasis Rev 2023; :